E
Eledon Pharmaceuticals, Inc. (ELDN)
NCM – Real Time Price. Currency in USD
3.90
+0.08 (2.09%)
At close: May 12, 2026, 4:00 PM EDT
3.98
+0.08 (2.15%)
Pre-market: May 13, 2026, 5:07 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
3.90
+0.08 (2.09%)
At close: May 12, 2026, 4:00 PM EDT
3.98
+0.08 (2.15%)
Pre-market: May 13, 2026, 5:07 AM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 7.40 | 6.05 | 10 | |
| Quick ratio | 7.40 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -373K | -374K | -359K | N/A | N/A |
| Operating Income | -40M | -43M | -71M | -83M | -83M |
| Net Income | -88M | -117M | -36M | -46M | -46M |
| EBITDA | -39M | -43M | -70M | -83M | -83M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -130 | 1.0 |
| Next quarter | N/A | -53.85 | 1.0 |
| Current year | N/A | -68.46 | 1.0 |
| Next year | N/A | 2.4 | 2.0 |
| Weighted average score | 1.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 40.16 | 47.62 | 2.67 | 8.5 |
| Y/Y | 999 | 76.59 | 82.81 | 25.79 | 10 |
| 3y average | 999 | 3.47 | 52.77 | -30.16 | 6.3 |
| 5y average | 999 | -39.14 | 15.83 | -35.76 | 5.3 |
| Weighted average score | 7.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $22.8M significantly exceed its total debt $641.0K, ensuring strong financial flexibility
Total current assets $135.7M exceed Total current liabilities $18.3M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$14.1M limits the company's ability to reinvest or pay down debt